Fusion Antibodies Ltd (FAB) ORD GBP0.04
1.25p
(10.64%)
- Add to watchlist
- Create an alert
- This stock can be held in a
1.25p
(10.64%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
1.25p
(10.64%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
11.75p
14.00p
20.50p
£14.78 million
11.75p
11.50p
4.20p
n/a
0.00p (0.00%) Previous:
0.00p
1,471,211
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/03/2025 | 31/03/2024 |
|---|---|---|
| Revenue (£m) | 1.96 | 1.14 |
| Profit before tax (£m) | (1.78) | (2.29) |
| Adjusted EPS (p): | (1.80) | (3.90) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Fusion Antibodies posts narrower half-year loss
24 November 2025 12:54
-
Fusion Antibodies expecting stronger second-half performance
16 October 2025 15:42
-
Fusion Antibodies reports further validation of OptiMAL platform
17 September 2025 09:42
-
Holding(s) in Company
25 November 2025 12:11
-
Half-year Financial Report
24 November 2025 07:00
-
Notice of Results
21 November 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.